(Circulation. 1997;96:1390-1397.)
© 1997 American Heart Association, Inc.
Articles |
Predictive Value of Electrophoretically Detected Lipoprotein(a) for Coronary Heart Disease and Cerebrovascular Disease in a Community-Based Cohort of 9936 Men and Women
From the Division of Endocrinology (T.T.N., H.S.A.-L.), Laboratory Medicine (R.D.E.), Biostatistics (D.O.H., K.R.B.), and Cardiology (T.E.K.), Mayo Clinic and Foundation, Rochester, Minn.
Background Elevated lipoprotein(a) [Lp(a)] levels have been associated with the presence of atherosclerotic disease. However, the results of prospective studies of Lp(a) and cardiovascular disease have been contradictory.
Methods and Results From 1968 through 1982, lipoprotein analysis was performed in 11 335 Olmsted County residents. Quantitative cholesterol and triglycerides were obtained along with semiquantitative Lp(a) levels based on electrophoretic pattern. Lp(a) bands were scored from 0 (absent) to 3 (increased). A cohort of 4967 men and 4968 women with no prior history of atherosclerotic disease who had baseline Lp(a) determinations were followed up for 14 years for development of coronary artery disease (CAD) and cerebrovascular disease (CVD). During 131 330 person-years of follow-up, there were 1848 CAD events and 841 CVD events. Age, diabetes, hypertension, cholesterol, and triglycerides were significantly and independently associated with an increased risk of CAD and CVD in men and women. There was a significant increase in the adjusted hazards ratio for CAD with increasing Lp(a) levels for men and women. For Lp(a) level 3, the hazard ratio was 1.9 (range, 1.3 to 2.9) in women and 1.6 (range, 1.0 to 2.5) in men. The adjusted hazard ratio for CVD showed an irregular association with Lp(a) levels in men and no association in women.
Conclusions In this cohort of 9936 men and women initially free of cardiovascular disease who were followed up for 14 years, Lp(a) was a significant predictor of risk of future CAD. Lp(a) was a weak risk factor for CVD in men and was not a significant predictor of CVD risk in women.
Key Words: lipoproteins • coronary disease • risk factors • cerebrovascular disorders
This article has been cited by other articles:
 |
|
 |
|
  A. Bennet, E. Di Angelantonio, S. Erqou, G. Eiriksdottir, G. Sigurdsson, M. Woodward, A. Rumley, G. D. O. Lowe, J. Danesh, and V. Gudnason Lipoprotein(a) Levels and Risk of Future Coronary Heart Disease: Large-Scale Prospective Data Arch Intern Med, March 24, 2008; 168(6): 598 - 608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Smolders, R. Lemmens, and V. Thijs Lipoprotein (a) and Stroke: A Meta-Analysis of Observational Studies Stroke, June 1, 2007; 38(6): 1959 - 1966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ohira, P. J. Schreiner, J. D. Morrisett, L. E. Chambless, W. D. Rosamond, and A. R. Folsom Lipoprotein(a) and Incident Ischemic Stroke: The Atherosclerosis Risk in Communities (ARIC) Study Stroke, June 1, 2006; 37(6): 1407 - 1412. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rubin, H. J. Kim, T. A. Pearson, S. Holleran, R. Ramakrishnan, and L. Berglund Apo[a] size and PNR explain African American-Caucasian differences in allele-specific apo[a] levels for small but not large apo[a] J. Lipid Res., May 1, 2006; 47(5): 982 - 989. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Shai, E. B. Rimm, S. E. Hankinson, C. Cannuscio, G. Curhan, J. E. Manson, N. Rifai, M. J. Stampfer, and J. Ma Lipoprotein (a) and coronary heart disease among women: beyond a cholesterol carrier? Eur. Heart J., August 2, 2005; 26(16): 1633 - 1639. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Berglund and R. Ramakrishnan Lipoprotein(a): An Elusive Cardiovascular Risk Factor Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2219 - 2226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Ariyo, C. Thach, R. Tracy, and the Cardiovascular Health Study Investigators Lp(a) Lipoprotein, Vascular Disease, and Mortality in the Elderly N. Engl. J. Med., November 27, 2003; 349(22): 2108 - 2115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Holmer, C. Hengstenberg, H.-G. Kraft, B. Mayer, M. Poll, S. Kurzinger, M. Fischer, H. Lowel, G. Klein, G. A.J. Riegger, et al. Association of Polymorphisms of the Apolipoprotein(a) Gene With Lipoprotein(a) Levels and Myocardial Infarction Circulation, February 11, 2003; 107(5): 696 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E Roeters van Lennep, H.T. Westerveld, D.W. Erkelens, and E. E van der Wall Risk factors for coronary heart disease: implications of gender Cardiovasc Res, February 15, 2002; 53(3): 538 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rubin, F. Paultre, C. H. Tuck, S. Holleran, R. G. Reed, T. A. Pearson, C. M. Thomas, R. Ramakrishnan, and L. Berglund Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians J. Lipid Res., February 1, 2002; 43(2): 234 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-L. Chien, F.-C. Sung, H.-C. Hsu, T.-C. Su, R.-S. Lin, and Y.-T. Lee Apolipoprotein A-I and B and Stroke Events in a Community-Based Cohort in Taiwan: Report of the Chin-Shan Community Cardiovascular Study Stroke, January 1, 2002; 33(1): 39 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rubin, T. A. Pearson, R. G. Reed, and L. Berglund Fluorescence-based, Nonradioactive Method for Efficient Detection of the Pentanucleotide Repeat (TTTTA)n Polymorphism in the Apolipoprotein(a) Gene Clin. Chem., October 1, 2001; 47(10): 1758 - 1762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Sarti, L. Pantoni, G. Pracucci, A. Di Carlo, P. Vanni, and D. Inzitari Lipoprotein(a) and Cognitive Performances in an Elderly White Population : Cross-Sectional and Follow-Up Data Stroke, July 1, 2001; 32(7): 1678 - 1683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Cui, R. S. Blumenthal, J. A. Flaws, M. K. Whiteman, P. Langenberg, P. S. Bachorik, and T. L. Bush Non-High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality Arch Intern Med, June 11, 2001; 161(11): 1413 - 1419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. B. Goldstein, R. Adams, K. Becker, C. D. Furberg, P. B. Gorelick, G. Hademenos, M. Hill, G. Howard, V. J. Howard, B. Jacobs, et al. Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association Circulation, January 2, 2001; 103(1): 163 - 182. [Full Text] [PDF]
|
|
|
|
|
|
W.D Ashton, K Nanchahal, and D.A Wood Body mass index and metabolic risk factors for coronary heart disease in women Eur. Heart J., January 1, 2001; 22(1): 46 - 55. [Abstract] [PDF]
|
|
|
|
|
|
L. B. Goldstein, R. Adams, K. Becker, C. D. Furberg, P. B. Gorelick, G. Hademenos, M. Hill, G. Howard, V. J. Howard, B. Jacobs, et al. Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association Stroke, January 1, 2001; 32(1): 280 - 299. [Full Text] [PDF]
|
|
|
|
|
|
F. Paultre, T. A. Pearson, H. F. C. Weil, C. H. Tuck, M. Myerson, J. Rubin, C. K. Francis, H. F. Marx, E. F. Philbin, R. G. Reed, et al. High Levels of Lp(a) With a Small Apo(a) Isoform Are Associated With Coronary Artery Disease in African American and White Men Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20(12): 2619 - 2624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. von Depka, U. Nowak-Gottl, R. Eisert, C. Dieterich, M. Barthels, I. Scharrer, A. Ganser, and S. Ehrenforth Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism Blood, November 15, 2000; 96(10): 3364 - 3368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Danesh, R. Collins, and R. Peto Lipoprotein(a) and Coronary Heart Disease : Meta-Analysis of Prospective Studies Circulation, September 5, 2000; 102(10): 1082 - 1085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Miwa, K. Nakagawa, N. Yoshida, Y. Taguchi, and H. Inoue Lipoprotein(a) is a risk factor for occurrence of acute myocardial infarction in patients with coronary vasospasm J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1200 - 1205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nishino, M. J. Malloy, J. Naya-Vigne, J. Russell, J. P. Kane, and R. F. Redberg Lack of association of lipoprotein(a) levels with coronary calcium deposits in asymptomatic postmenopausal women J. Am. Coll. Cardiol., February 1, 2000; 35(2): 314 - 320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Foody, J. A. Milberg, K. Robinson, G. L. Pearce, D. W. Jacobsen, and D. L. Sprecher Homocysteine and Lipoprotein(a) Interact to Increase CAD Risk in Young Men and Women Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 493 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Seman, C. DeLuca, J. L. Jenner, L. A. Cupples, J. R. McNamara, P. W.F. Wilson, W. P. Castelli, J. M. Ordovas, and E. J. Schaefer Lipoprotein(a)-Cholesterol and Coronary Heart Disease in the Framingham Heart Study Clin. Chem., July 1, 1999; 45(7): 1039 - 1046. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. KRONENBERG, U. NEYER, K. LHOTTA, E. TRENKWALDER, M. AUINGER, A. PRIBASNIG, T. MEISL, P. KÖNIG, and H. DIEPLINGER The Low Molecular Weight Apo(a) Phenotype Is an Independent Predictor for Coronary Artery Disease in Hemodialysis Patients: A ProspectiveFollow-Up J. Am. Soc. Nephrol., May 1, 1999; 10(5): 1027 - 1036. [Abstract] [Full Text]
|
|
|
|
|
|
M. Pahor, M. B. Elam, R. J. Garrison, S. B. Kritchevsky, and W. B. Applegate Emerging Noninvasive Biochemical Measures to Predict Cardiovascular Risk Arch Intern Med, February 8, 1999; 159(3): 237 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Y. Craig, L. M. Neveux, G. E. Palomaki, M. M. Cleveland, and J. E. Haddow Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies Clin. Chem., November 1, 1998; 44(11): 2301 - 2306. [Abstract] [Full Text] [PDF]
|
|